Department of Breast Tumor Diagnosis
Department of Breast Tumor Diagnosis

The Department of Breast Tumor Diagnosis is the first formally established unit in China dedicated to the imaging diagnosis of breast-related diseases, as well as performing pathological biopsy procedures and genetic sequencing analysis. It currently employs 9 imaging diagnostic physicians, 1 technician, and 2 technical assistants, including 2 doctoral candidates and 7 master's candidates. The current head of the Breast Diagnosis Specialty, Gong Chang, is a Chief Physician in Breast Surgery, holds a Doctorate in Surgery, and serves as a doctoral supervisor. She was state-sponsored to study breast surgery and breast diagnostic clinical techniques in the United Kingdom and France. The department is equipped with advanced diagnostic and interventional devices, including: digital color ultrasound, automated breast volume scanner (ABVS), digital breast tomosynthesis (DBT) systems, breast magnetic resonance imaging (MRI) equipment, dual-energy X-ray absorptiometry (DXA) for bone density, ductoscopy systems, breast vacuum-assisted minimally invasive biopsy systems, stereotactic breast biopsy systems guided by mammographic 3D localization, breast core needle and fine-needle aspiration biopsy devices, as well as breast lesion marker clip and Hookwire localization systems.

Featured Medical Technology

In the field of imaging diagnosis, the department integrates and synthesizes various imaging findings of breast diseases with clinical signs, accumulating extensive experience in the diagnosis and management of breast conditions. It possesses particularly rich clinical and practical expertise in the precise diagnosis of early-stage breast cancer. Regarding pathological biopsies, the department performs digital mammographic 3D stereotactic localization, ultrasound-guided vacuum-assisted core biopsy, core needle and fine-needle aspiration biopsies of breast tissue and lymph nodes, Hookwire localization, and breast tissue marker clip placement, all of which safeguard the accurate diagnosis and treatment of breast diseases. Concurrently, the department actively engages in research and development of artificial intelligence products for breast imaging and pathology, striving to establish itself as Guangdong Province's diagnostic center for complex breast diseases. Furthermore, it operates the world's most advanced "Mobile Breast Cancer Screening Unit for Chinese Women," equipped with technology capable of detecting the earliest stages of breast cancer.

Scientific Research Results

Under the leadership of Chief Physician Gong Chang, the Breast Diagnosis Specialty closely integrates with clinical practice and focuses on breast cancer screening and early, precise diagnosis and treatment to conduct relevant clinical research. The department leads projects including the National Key Research and Development Program of the Ministry of Science and Technology (serving as the project leader unit), 6 National Natural Science Foundation projects, and 7 provincial/ministerial-level funds. It has published over 50 SCI papers in journals related to surgery, oncology, and imaging, such as Cancer Cell, Nature Communications, the European Journal, and JSO. The department has obtained 1 patent, filed applications for 10 patents, and applied for 1 software copyright. It has participated in compiling multiple Chinese and English monographs, such as Breast-Conserving Therapy for Breast Cancer published by People's Medical Publishing House and Adv Exp Med Biol. published by Springer. The department actively fosters talent development. Chief Physician Gong Chang has been selected for honors including the Ministry of Education's New Century Excellent Talents, the Guangdong Outstanding Youth Fund, the Guangdong Special Support Program for Outstanding Young Talents (Thousands, Hundreds, Tens Project), Guangdong Outstanding Young Medical Talent, and Guangzhou Zhujiang Science and Technology New Star.
The Breast Diagnosis Specialty has successfully held two sessions of the high-quality training course "Clinical Application of Metal Markers in Precise Localization and Surgical Resection for Breast Surgery" and multiple sessions of the "Standardized Operation Training Course for Ultrasound-Guided Vacuum-Assisted Minimally Invasive Biopsy." These training programs have covered over 40 institutions both within and outside the province, with influence radiating nationwide, and have received unanimous praise from participating trainees.